Preliminary data from human embryonic stem cell trials for two degenerative eye disorders are promising, but challenges remain for more complex tissues.
Preliminary data from human embryonic stem cell trials for two degenerative eye disorders are promising, but challenges remain for more complex tissues.
The US company investigating the use of human embryonic stem cells to treat a type of macular dystrophy expands its clinical trials to the UK.
Page 1 of 1